May. 5 at 8:22 PM
$ARDT Financial Performance Summary
The Company's first quarter 2026 results included a
$10.9 million gain, included in other operating expenses, from an increase in the carrying value of an investment option it holds in a privately held company.
For the first quarter of 2026:
Total revenue grew 7.0% year-over-year to
$1,602 million, driven primarily by a 2.0% increase in adjusted admissions and a 5.5% increase in net patient service revenue per adjusted admission.
Net income attributable to Ardent Health was
$40 million, or
$0.28 per diluted share, compared to net income attributable to Ardent Health of
$41 million, or
$0.29 per diluted share, in the first quarter of 2025.
Adjusted EBITDA increased 26.3% year-over-year to
$124 million. Excluding the
$10.9 million gain discussed above, adjusted EBITDA grew 15%.